Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Unidad de Cirugía Artroscópica (UCA) is a premier medical and research center located in Vitoria-Gasteiz, Spain, specializing in advanced orthopedic surgery and regenerative medicine. Founded and led by Dr. Mikel Sánchez, the unit is globally recognized for pioneering the clinical application of Plasma Rich in Growth Factors (PRGF) to treat musculoskeletal injuries. UCA integrates high-level clinical practice with translational research, focusing on minimally invasive arthroscopic techniques and biological therapies for conditions such as osteoarthritis and sports-related trauma. The center maintains a strategic partnership with the BTI Biotechnology Institute to develop and refine regenerative technologies. Its reputation is further bolstered by its history of treating elite professional athletes and its extensive contribution to scientific literature in the field of orthopedics.
Beyond the preview
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Follow clinical development from trial design and recruitment through results.
Explore licensing agreements, acquisitions, and the assets behind each deal.
Trace financing activity and the investors behind a company’s development.
Compare peer pipelines by target, modality, and therapeutic area.
Explore technology platforms and the patent landscape around relevant assets.
Connect company news and source material to the questions you’re investigating.
See how Gosset can support your research on Unidad de Cirugia Artroscopica.